Sectors
ARMP
Armata Pharmaceuticals, Inc.
4.27
100 x 4.15
400 x 4.27
bid
ask
+
0.09
2.12%
09:59 AM
timesize
| Ytd | -32.03% | |
| 1y | 39.05% |
4.20
day range
4.27
2.94
52 week range
16.34
| Open | 4.24 | Prev Close | 4.18 | Low | 4.20 | High | 4.27 | Mkt Cap | 158.72M |
| Vol | 5.87K | Avg Vol | 244.45K | EPS | -5.29 | P/E | N/A | Forward P/E | -1.30 |
| Beta | 1.34 | Short Ratio | 0.86 | Inst. Own | 3.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 4.85 | 200-d Avg | 7.41 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 12.82M | ||
| Research and Development Expense | 7.59M | ||
| Selling, General and Administrative Expense | 5.24M | ||
| Operating Income | -12.82M | ||
| Interest Expense | 6.63M | ||
| Net Income | 74.14M | ||
| Net Income Common Stock | 74.14M | ||
| Net Income Common Stock (USD) | 74.14M | ||
| Consolidated Income | 74.14M | ||
| Earnings per Basic Share | 2.02 | ||
| Earnings per Basic Share (USD) | 2.02 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | 80.78M | ||
| Earning Before Interest & Taxes (USD) | 80.78M | ||
| Weighted Average Shares | 36.75M | ||
| Weighted Average Shares Diluted | 62.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.07M | ||
| Cash and Equivalents (USD) | 28.07M | ||
| Trade and Non-Trade Receivables | 2.53M | ||
| Current Assets | 27.16M | ||
| Property, Plant & Equipment Net | 44.11M | ||
| Total Assets | 89.95M | ||
| Debt Current | 246.11M | ||
| Total Debt | 313.95M | ||
| Current Liabilities | 250.20M | ||
| Debt Non-Current | 67.85M | ||
| Total Liabilities | 321.12M | ||
| Accumulated Retained Earnings (Deficit) | -542.74M | ||
| Shareholders Equity | -231.17M | ||
| Shareholders Equity (USD) | -231.17M | ||
| Assets Non-Current | 62.79M | ||
| Total Debt (USD) | 313.95M | ||
| Goodwill and Intangible Assets | 3.49M | ||
| Liabilities Non-Current | 70.92M | ||
| Trade and Non-Trade Payables | 1.86M | ||
| Tax Liabilities | 3.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 591.00K | ||
| Net Cash Flow from Financing | 27.88M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 19.20M | ||
| Capital Expenditure | -17.00K | ||
| Issuance (Purchase) of Equity Shares | 2.88M | ||
| Issuance (Repayment) of Debt Securities | 25.00M | ||
| Net Cash Flow from Investing | -17.00K | ||
| Net Cash Flow from Operations | -8.67M | ||
| Share Based Compensation | 3.39M | ||